Success Stories: Post-doctoral Fellow in Translational Immunology Earns NIW Approval with NAILG’s Expert Support without any Request for Evidence [RFE]
Client’s Testimonial:
“Excellent Team! Great response time and meticulous working style! Drafting of self-explanatory starting modules to continuously support critical and crisp writing. Highly recommended! Happy to work with, best in business!”
On April 8th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Post-doctoral Fellow in the Field of Translational Immunology (Approval Notice).
General Field: Translational Immunology
Position at the Time of Case Filing: Post-doctoral Fellow
Country of Origin: India
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: April 8th, 2025
Processing Time: 10 months, 11 days
Case Summary:
With a strong foundation in immunology and translational research, our client has demonstrated an exceptional ability to advance public health through scientific innovation. When he approached North America Immigration Law Group (NAILG) for assistance with his I-140 National Interest Waiver (NIW) petition, we conducted a comprehensive review of his academic and professional background. Recognizing the national significance of his research, we developed a tailored petition strategy that ultimately led to his successful NIW approval.
To establish his critical role as a researcher, we highlighted several key aspects of his contributions:
- 10 peer-reviewed journal articles, including five as first or co-first author
- 889 citations of his work, with references by researchers in at least 63 countries, underscoring his international influence
- Over 50 peer reviews for respected journals and service as a guest editor, affirming his leadership in the field
- Research funding from top-tier institutions, including the National Institutes of Health (NIH), the National Institute of Environmental Health Sciences (NIEHS), the National Institute of Allergy and Infectious Disease (NIAID), the Food Allergy Science Initiative, the Advanced Photon Source of the Argonne National Laboratory, and the U.S. Department of Energy's Office of Science.
One expert recommender powerfully summarized his national and global impact:
"It is evident that [client] is a researcher operating at the highest echelon of the field of translational immunology. He has demonstrated this through important research to understand copper and peanut allergies and effective methods of treatment. He has advanced our understanding of effective antibodies for peanut allergy immunotherapy and of the underlying mechanisms of both copper and peanut allergy. As allergies are increasingly common and pose a lethal danger to those affected, the importance of [client’s] ongoing research related to these must not be understated. He continues to greatly advance understanding and treatment for these conditions to the benefit of national and global health interests."
With a proven record of impactful research, scholarly recognition, and institutional support, our client stands as a valuable contributor to the U.S. biomedical community. We are proud that our strategic guidance played a role in his NIW approval and are honored to support his journey in advancing public health through science. Thus, he received his approval despite waiting for a long but, without any request for evidence [RFE]. We thank him for trusting the North America Immigration Law Group and wish him continued success in his groundbreaking work.